Amundi’s Antares Pharma, Inc. ATRS Stock Holding History

Amundi’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,451,789	Closed	-$13.9M	–	1744
2022 Q1	$13.9M	Buy	3,451,789 +953,452	+38%	+$3.46M	0.01%	740
2021 Q4	$8.84M	Buy	2,498,337 +333,866	+15%	+$1.17M	0.01%	871
2021 Q3	$7.88M	Buy	2,164,471 +38,710	+2%	+$157K	0.01%	903
2021 Q2	$9.27M	Buy	+2,125,761	New	+$8.66M	0.01%	865

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Amundi's ATRS Position: Q2 2022 in Review

Amundi sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 3,451,789 shares — an estimated $13.9M sold.

Amundi first reported a position in ATRS in Q2 2021 and held it in 4 quarters. The position peaked at $13.9M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Amundi reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Amundi sold 3,451,789 Antares Pharma, Inc. shares in Q2 2022, an estimated $13.9M.
Amundi first reported a position in Antares Pharma, Inc. in Q2 2021 and held it in 4 quarters.
Amundi's Antares Pharma, Inc. position peaked at $13.9M in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Amundi's 13F filing for Q2 2022, filed 15 Aug 2022.